Ellis, M.H.; Tadmor, T.; Yekutiel, N.; Chodick, G.; Levy, M.; Sharf, G.; Ben Zvi, N.; Leef, R.; Feine, O.; Shavit, O.
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice. J. Clin. Med. 2024, 13, 3390.
https://doi.org/10.3390/jcm13123390
AMA Style
Ellis MH, Tadmor T, Yekutiel N, Chodick G, Levy M, Sharf G, Ben Zvi N, Leef R, Feine O, Shavit O.
Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice. Journal of Clinical Medicine. 2024; 13(12):3390.
https://doi.org/10.3390/jcm13123390
Chicago/Turabian Style
Ellis, Martin H., Tamar Tadmor, Naama Yekutiel, Gabriel Chodick, Moti Levy, Giora Sharf, Nana Ben Zvi, Raanan Leef, Oren Feine, and Oren Shavit.
2024. "Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice" Journal of Clinical Medicine 13, no. 12: 3390.
https://doi.org/10.3390/jcm13123390
APA Style
Ellis, M. H., Tadmor, T., Yekutiel, N., Chodick, G., Levy, M., Sharf, G., Ben Zvi, N., Leef, R., Feine, O., & Shavit, O.
(2024). Clinical and Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice. Journal of Clinical Medicine, 13(12), 3390.
https://doi.org/10.3390/jcm13123390
